Transcriptional master regulator analysis in breast cancer genetic networks

被引:33
|
作者
Tovar, Hugo [1 ]
Garcia-Herrera, Rodrigo [1 ]
Espinal-Enriquez, Jesus [1 ,2 ]
Hernandez-Lemus, Enrique [1 ,2 ]
机构
[1] Natl Inst Genom Med INMEGEN, Computat Genom Dept, Mexico City, DF, Mexico
[2] Natl Autonomous Univ Mexico UNAM, Ctr Complex Sci, Mexico City, DF, Mexico
关键词
Transcriptional master regulators; Breast cancer; Gene regulatory networks; Systems biology; HISTOLOGIC GRADE; PROSTATE-CANCER; EXPRESSION; PROTEIN; SIGNATURE; MIGRATION; TFDP3; OVEREXPRESSION; METASTASIS; APOPTOSIS;
D O I
10.1016/j.compbiolchem.2015.08.007
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gene regulatory networks account for the delicate mechanisms that control gene expression. Under certain circumstances, gene regulatory programs may give rise to amplification cascades. Such transcriptional cascades are events in which activation of key-responsive transcription factors called master regulators trigger a series of gene expression events. The action of transcriptional master regulators is then important for the establishment of certain programs like cell development and differentiation. However, such cascades have also been related with the onset and maintenance of cancer phenotypes. Here we present a systematic implementation of a series of algorithms aimed at the inference of a gene regulatory network and analysis of transcriptional master regulators in the context of primary breast cancer cells. Such studies were performed in a highly curated database of 880 microarray gene expression experiments on biopsy-captured tissue corresponding to primary breast cancer and healthy controls. Biological function and biochemical pathway enrichment analyses were also performed to study the role that the processes controlled - at the transcriptional level - by such master regulators may have in relation to primary breast cancer. We found that transcription factors such as AGTR2, ZNF132, TFDP3 and others are master regulators in this gene regulatory network. Sets of genes controlled by these regulators are involved in processes that are well-known hallmarks of cancer. This kind of analyses may help to understand the most upstream events in the development of phenotypes, in particular, those regarding cancer biology. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:67 / 77
页数:11
相关论文
共 50 条
  • [31] TAp63 Is a Master Transcriptional Regulator of Lipid and Glucose Metabolism
    Su, Xiaohua
    Gi, Young Jin
    Chakravarti, Deepavali
    Chan, Io Long
    Zhang, Aijun
    Xia, Xuefeng
    Tsai, Kenneth Y.
    Flores, Elsa R.
    CELL METABOLISM, 2012, 16 (04) : 511 - 525
  • [32] Transcriptional network inference and master regulator analysis of the response to ribosome-inactivating proteins in leukemia cells
    Mercatelli, Daniele
    Bortolotti, Massimo
    Giorgi, Federico M.
    TOXICOLOGY, 2020, 441
  • [33] HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer
    Yuan, Zhu
    Sanders, Andrew J.
    Ye, Lin
    Jiang, Wen G.
    HISTOLOGY AND HISTOPATHOLOGY, 2010, 25 (10) : 1331 - 1340
  • [34] LUZP1 is an understudied transcriptional regulator in triple negative breast cancer (TNBC).
    Wang, Junkai
    Chan, Doug
    Kim, Beom-Jun
    Echeverria, Gloria V.
    Jaehnig, Eric
    Zhang, Bing
    Ellis, Matthew J.
    CANCER RESEARCH, 2021, 81 (13)
  • [35] NFIX as a Master Regulator for Lung Cancer Progression
    Rahman, Nor I. A.
    Murad, Nor A. Abdul
    Mollah, Mohammad M.
    Jamal, Rahman
    Harun, Roslan
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [36] Pancreatic cancer comprises co-existing transcriptional states regulated by distinct master regulator programs.
    Laise, Pasquale
    Turunen, Mikko
    Maurer, Hans Carlo
    Garcia, Alvaro Curiel
    Elyada, Ela
    Schmierer, Bernhard
    Tomassoni, Lorenzo
    Worley, Jeremy
    Alvarez, Mariano J.
    Kesner, Jordan
    Tan, Xiangtian
    Tagore, Somnath
    Fernandez, Ester Calvo
    Wong, Kelly
    Wang, Alexander L. E.
    Ge, Sabrina
    Iuga, Alina C.
    Griffin, Aaron T.
    Wong, Winston
    Manji, Gulam A.
    Notta, Faiyaz
    Tuveson, David A.
    Olive, Kenneth P. P.
    Califano, Andrea
    CANCER RESEARCH, 2022, 82 (22) : 5 - 5
  • [37] The Role of Nitric Oxide in Cancer: Master Regulator or NOt?
    Khan, Faizan H.
    Dervan, Eoin
    Bhattacharyya, Dibyangana D.
    McAuliffe, Jake D.
    Miranda, Katrina M.
    Glynn, Sharon A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 30
  • [38] Researchers discover master regulator of cancer metastasis
    Telfer, Caroline
    EPIGENOMICS, 2013, 5 (04) : 360 - 360
  • [39] Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
    Gong, Yongxing
    Zack, Travis Ian
    Morris, Luc G. T.
    Lin, Kan
    Hukkelhoven, Ellen
    Raheja, Radhika
    Tan, I-Li
    Turcan, Sevin
    Veeriah, Selvaraju
    Meng, Shasha
    Viale, Agnes
    Schumacher, Steven E.
    Palmedo, Perry
    Beroukhim, Rameen
    Chan, Timothy A.
    NATURE GENETICS, 2014, 46 (06) : 588 - 594
  • [40] Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
    Yongxing Gong
    Travis Ian Zack
    Luc G T Morris
    Kan Lin
    Ellen Hukkelhoven
    Radhika Raheja
    I-Li Tan
    Sevin Turcan
    Selvaraju Veeriah
    Shasha Meng
    Agnes Viale
    Steven E Schumacher
    Perry Palmedo
    Rameen Beroukhim
    Timothy A Chan
    Nature Genetics, 2014, 46 : 588 - 594